Fig. 1From: The effects of bioactive components from the rhizome of Salvia miltiorrhiza (Danshen) on the characteristics of Alzheimer’s diseasePhase 3 and 4 clinical trials in 2018. Asterisk, completed; Underline, failedBack to article page